Compare Humana Inc (HUM) vs Wendys Co (WEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Wendys Co — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Wendys Co trades at $6.22 (market cap $1.16B). The key difference: Humana Inc is far larger — about 41× Wendys Co's market cap, and Wendys Co pays the higher dividend (4.59%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Wendys Co for 77 Days on average.
| HUM | WEN | |
|---|---|---|
Market Cap | $47.61B | $1.16B |
Volume | 1,827,332 | 4,715,639 |
Sector | Health | Consumer Cyclical |
52-Week High | $409.85 | $9.33 |
52-Week Low | $163.67 | $6.10 |
Typical Hold Time | 53 Days | 77 Days |
Enterprise Value | $54.97B | $4.90B |
Dividend Yield | 0.89% | 4.59% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
Wendy's (WEN) trades at $6.22, up 0.97% today but remains under significant pressure with a bearish technical outlook. The stock shows attractive valuation metrics including a P/E of 9.25 and P/S of 0.53, though fundamentals reveal declining profitability with net income margin dropping to 5.72% in 2025. Recent news highlights challenges including a major franchisee bankruptcy filing and six consecutive quarters of same-store sales declines, creating headwinds for the burger chain.
Despite low valuations and consistent earnings beats, Wendy's faces substantial operational challenges including franchisee instability and competitive pressures. The consensus price target of $7.58 suggests 22% upside potential, but investor sentiment remains cautious given the deteriorating fundamentals and bearish technical signals. Recovery depends on successful execution under new CEO Bob Wright and reversing negative sales trends.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Wendys Co
The Wendy's Company is the second-largest burger quick-service restaurant, or QSR, chain in the United States by systemwide sales, with $11.1 billion in 2021, narrowly edging Burger King ($10.3 billion) and clocking in well behind wide-moat McDonald's ($45.7 billion). After divestitures of Tim Hortons (2006) and Arby's (2011), the firm manages just the burger banner, generating sales across a footprint that spans almost 7,000 total units in 30 countries. Wendy's generates revenue from the sale of hamburgers, chicken sandwiches, salads, and fries throughout its company-owned footprint, through franchise royalty and marketing fund payments remitted by its franchisees, which account for 94% of stores, and through franchise flipping and advisory fees.
Read more on WEN →
